×
About 1,908 results

ALLMedicine™ Methamphetamine Center

Research & Reviews  757 results

Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Wh...
https://doi.org/10.1007/s10461-022-03929-6
AIDS and Behavior; Blair CS, Gandhi M et. al.

Nov 23rd, 2022 - Methamphetamine (MA) use is associated with HIV transmission among men who have sex with men (MSM) and lapses in medication adherence. Contingency Management (CM) is effective in reducing MA use, but studies of CM to support adherence to HIV preve...

Prevalence, demographics, and clinical correlates of antisocial personality disorder in...
https://doi.org/10.1111/ajad.13361
The American Journal on Addictions; Li Y, Tian Y et. al.

Nov 21st, 2022 - Antisocial personality disorder (ASPD) is very common among methamphetamine (MA) patients, but very few studies have been conducted in China. This study aimed to investigate the prevalence and clinical correlates of ASPD among Chinese MA patients....

Clinical Management of Psychostimulant Withdrawal: Review of the Evidence.
https://doi.org/10.1111/add.16093
Addiction (Abingdon, England); Li MJ, Shoptaw SJ

Nov 20th, 2022 - It is estimated that a majority of people who use psychostimulants, particularly methamphetamine (MA) and cocaine, experience withdrawal upon abstinence from sustained use. This review of clinical research reports the evidence regarding biomedical...

Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibi...
https://doi.org/10.1016/j.drugalcdep.2022.109692
Drug and Alcohol Dependence; Acheson LS, Ezard N et. al.

Nov 19th, 2022 - There is no effective treatment for methamphetamine withdrawal. This study aimed to determine the feasibility and safety of a tapering dose of lisdexamfetamine for the treatment of acute methamphetamine (MA) withdrawal. Open-label, single-arm pilo...

The roles of K+-dependent Na+/Ca2+ exchanger 2 (NCKX2) in methamphetamine-induced behav...
https://doi.org/10.1016/j.neulet.2022.136952
Neuroscience Letters; Liang M, Chen G et. al.

Nov 7th, 2022 - Drug addiction, including methamphetamine (METH) addiction, is a significant public health and social issue. Perturbations in intracellular Ca2+ homeostasis are associated with drug addiction. K+-dependent Na+/Ca2+ exchanger 2 (NCKX2) is located o...

see more →

News  6 results

How Meth Abuse May Affect Visuospatial Processing
https://www.mdedge.com/fedprac/article/201483/mental-health/how-meth-abuse-may-affect-visuospatial-processing?channel=94
Jan Dyer

May 26th, 2019 - Methamphetamine (MA) abuse has been linked to psychological problems, such as depression, anxiety, and psychosis. It also has been linked to problems in everyday functioning (eg, impulsivity), and neurocognitive deficits in attention, memory, lear.

Methamphetamine Abuse Exacts Heavy Toll on the Heart
https://www.medscape.com/viewarticle/894485

Mar 27th, 2018 - A new study sheds light on two poorly understood cardiac complications of methamphetamine (MA) abuse: pulmonary arterial hypertension (PAH) and dilated cardiomyopathy (CMP).   In what is believed to be the largest case series to date, investigator...

'Bath Salts' More Addictive Than Meth
https://www.medscape.com/viewarticle/807962

Jul 17th, 2013 - A synthetic compound found in illicit drugs known as "bath salts" may be more addictive than methamphetamine (meth), new research suggests. A set of tests showed that after a group of rats were exposed to the chemical 3,4-methylenedioxypyrovaleron...

'Bath Salts' More Addictive Than Meth
https://www.staging.medscape.com/viewarticle/807962

Jul 17th, 2013 - A synthetic compound found in illicit drugs known as "bath salts" may be more addictive than methamphetamine (meth), new research suggests. A set of tests showed that after a group of rats were exposed to the chemical 3,4-methylenedioxypyrovaleron...

Managing 'Meth Mouth'
https://www.staging.medscape.com/viewarticle/750195

Oct 3rd, 2011 - Methamphetamine Use and Addiction Methamphetamine (MA) is a schedule 2 central nervous system stimulant, which in low doses has been US Food and Drug Administration approved for use in the treatment of narcolepsy and attention-deficit/hyperactivit...

see more →